The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 2008, 180: 2062-2068.
Copyright © 2008 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Kim, D.-H.
Right arrow Articles by Kang, C.-Y.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, D.-H.
Right arrow Articles by Kang, C.-Y.

4-1BB Engagement Costimulates NKT Cell Activation and Exacerbates NKT Cell Ligand-Induced Airway Hyperresponsiveness and Inflammation1

Dong-Hyeon Kim*, Woo-Sung Chang*, Yoon-Sook Lee*, Kyoo-A Lee*, Yoon-Keun Kim{dagger}, Byoung S. Kwon{ddagger} and Chang-Yuil Kang2,*

* Laboratory of Immunology and Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul, Republic of Korea; {dagger} Division of Molecular and Life Science, Department of Life Science, Postech Biotech Center, Pohang University of Science and Technology, Pohang, Kyungbuk, Republic of Korea; and {ddagger} Immunomodulation Research Center and Department of Biological Sciences, University of Ulsan, Ulsan, Republic of Korea

Multiple studies have demonstrated that 4-1BB (CD137), a member of the TNF receptor superfamily, is expressed on several immune cells including activated T cells. However, the expression and the role of 4-1BB on natural killer T (NKT) cells have not been fully characterized. In this study, it was shown that 4-1BB was not expressed on naive NKT cells but was rapidly induced on activated NKT cells by TCR engagement with {alpha}-galactosylceramide ({alpha}-GalCer). Also, 4-1BB signaling provided by 3H3, an agonistic anti-4-1BB mAb, promoted NKT cell activation resulting in enhanced cytokine production of NKT cells driven by {alpha}-GalCer. When NKT cell-driven airway immune responses were evaluated by intranasal administration of {alpha}-GalCer, airway hyperresponsiveness (AHR) and lung inflammation were significantly more aggravated in mice treated with 3H3 and {alpha}-GalCer than in mice treated with {alpha}-GalCer alone. These aggravations were accompanied by up-regulation of IL-4, IL-13, and IFN-{gamma} production. Interestingly, AHR was not developed in IL-4R{alpha}-deficient mice treated with {alpha}-GalCer with or without 3H3 but was exacerbated in IFN-{gamma}-deficient mice. Our study suggests that 4-1BB on NKT cells functions as a costimulatory molecule and exacerbates the induction of NKT cell-mediated AHR, which is dependent on the IL-4R{alpha}-mediated pathway.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by a Korea Research Foundation Grant from the Korean Government (Ministry of Education and Human Resource Development) (KRF-2006-312-E00093).

2 Address correspondence and reprint requests to Dr. Chang-Yuil Kang, Laboratory of Immunology and Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Shillim-9-dong, Kwanak-gu, Seoul 151-742, Republic of Korea. E-mail address: cykang{at}snu.ac.kr

3 Abbreviations used in this paper: NKT, natural killer T; AHR, airway hyperresponsiveness; {alpha}-GalCer, {alpha}-galactosylceramide; BAL, bronchoalveolar lavage; BALF, BAL fluid.




This article has been cited by other articles:


Home page
J. Immunol.Home page
O. Akbari, P. Stock, E. H. Meyer, G. J. Freeman, A. H. Sharpe, D. T. Umetsu, and R. H. DeKruyff
ICOS/ICOSL Interaction Is Required for CD4+ Invariant NKT Cell Function and Homeostatic Survival
J. Immunol., April 15, 2008; 180(8): 5448 - 5456.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2008 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2008 by The American Association of Immunologists, Inc. All rights reserved.